INVO Bioscience (INVO) Competitors $0.75 -0.01 (-1.32%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO vs. SSKN, LYRA, PYPD, PETV, ICU, PAVM, NURO, TTOO, BTCY, and PSTVShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), PolyPid (PYPD), PetVivo (PETV), SeaStar Medical (ICU), PAVmed (PAVM), NeuroMetrix (NURO), T2 Biosystems (TTOO), Biotricity (BTCY), and Plus Therapeutics (PSTV). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. STRATA Skin Sciences Lyra Therapeutics PolyPid PetVivo SeaStar Medical PAVmed NeuroMetrix T2 Biosystems Biotricity Plus Therapeutics INVO Bioscience (NASDAQ:INVO) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Do insiders & institutionals believe in INVO or SSKN? 12.0% of INVO Bioscience shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 3.5% of INVO Bioscience shares are owned by insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, INVO or SSKN? INVO Bioscience has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Which has stronger valuation and earnings, INVO or SSKN? INVO Bioscience has higher earnings, but lower revenue than STRATA Skin Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Bioscience$5.77M0.50-$8.03MN/AN/ASTRATA Skin Sciences$32.68M0.37-$10.83M-$2.66-1.09 Does the MarketBeat Community prefer INVO or SSKN? STRATA Skin Sciences received 216 more outperform votes than INVO Bioscience when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 46.67% of users gave INVO Bioscience an outperform vote. CompanyUnderperformOutperformINVO BioscienceOutperform Votes746.67% Underperform Votes853.33% STRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% Is INVO or SSKN more profitable? STRATA Skin Sciences has a net margin of -28.72% compared to INVO Bioscience's net margin of -122.79%. INVO Bioscience's return on equity of 0.00% beat STRATA Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets INVO Bioscience-122.79% N/A -36.94% STRATA Skin Sciences -28.72%-69.33%-17.55% Does the media favor INVO or SSKN? In the previous week, INVO Bioscience's average media sentiment score of 0.00 equaled STRATA Skin Sciences'average media sentiment score. Company Overall Sentiment INVO Bioscience Neutral STRATA Skin Sciences Neutral SummarySTRATA Skin Sciences beats INVO Bioscience on 7 of the 11 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.17M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E RatioN/A25.0190.0517.20Price / Sales0.5045.901,117.09117.04Price / CashN/A43.4443.1037.85Price / Book-0.367.094.784.78Net Income-$8.03M$13.64M$120.31M$225.60M7 Day Performance-8.54%-2.93%-1.92%-1.23%1 Month Performance-14.29%-1.42%13.65%0.46%1 Year Performance-39.02%39.20%28.34%15.24% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$0.75-1.3%N/A-35.3%$3.17M$5.77M0.0025SSKNSTRATA Skin Sciences1.0262 of 5 stars$2.99-0.3%N/A-51.5%$12.47M$32.68M-1.11120LYRALyra Therapeutics2.4053 of 5 stars$0.19+1.9%$4.50+2,319.4%-96.1%$12.18M$1.47M-0.1250Gap DownPYPDPolyPid2.3344 of 5 stars$2.43-6.9%$12.00+393.8%-17.6%$11.66MN/A-0.3080Analyst RevisionHigh Trading VolumePETVPetVivoN/A$0.42+1.8%N/A-61.2%$8.59M$970,000.00-0.8520News CoverageGap UpICUSeaStar Medical0.1058 of 5 stars$1.84-7.5%N/A-81.6%$8.21M$68,000.00-0.172PAVMPAVmed3.7482 of 5 stars$0.74-3.2%$19.00+2,467.6%-84.8%$8.19M$2.45M-0.1890News CoverageNURONeuroMetrix0.7886 of 5 stars$3.90+2.4%N/A+16.4%$7.97M$3.77M-0.8320Gap DownTTOOT2 Biosystems2.7789 of 5 stars$0.37+2.6%$5.00+1,234.8%-92.7%$7.88M$7.19M0.00180Analyst ForecastGap UpHigh Trading VolumeBTCYBiotricityN/A$0.30-5.1%N/A-74.1%$7.37M$12.06M-0.2340PSTVPlus Therapeutics1.5574 of 5 stars$1.12-11.8%$13.50+1,105.4%-42.3%$6.61M$4.91M-0.4420 Related Companies and Tools Related Companies STRATA Skin Sciences Competitors Lyra Therapeutics Competitors PolyPid Competitors PetVivo Competitors SeaStar Medical Competitors PAVmed Competitors NeuroMetrix Competitors T2 Biosystems Competitors Biotricity Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INVO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
